NCT/Study#

NCT04106167 /

FT-003

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

DISEASE GROUP:
Phase 1
current phase:
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: